Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP869741.RARrXXSyQevKDMBHCdlObxK7LRI5KwxKsEOLk-Ld-8QZo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP869741.RARrXXSyQevKDMBHCdlObxK7LRI5KwxKsEOLk-Ld-8QZo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP869741.RARrXXSyQevKDMBHCdlObxK7LRI5KwxKsEOLk-Ld-8QZo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP869741.RARrXXSyQevKDMBHCdlObxK7LRI5KwxKsEOLk-Ld-8QZo130_provenance.
- NP869741.RARrXXSyQevKDMBHCdlObxK7LRI5KwxKsEOLk-Ld-8QZo130_assertion description "[We identified a general increase in DNA promoter methylation levels in four choriocarcinoma (CCA)-derived lines and transformed HTR-8/SVneo cells, including hypermethylation of several genes regularly seen in human cancers, while other differences in methylation were noted in genes linked to immune responsiveness, cell morphology, development and migration across the different cell populations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869741.RARrXXSyQevKDMBHCdlObxK7LRI5KwxKsEOLk-Ld-8QZo130_provenance.
- NP869741.RARrXXSyQevKDMBHCdlObxK7LRI5KwxKsEOLk-Ld-8QZo130_assertion evidence source_evidence_literature NP869741.RARrXXSyQevKDMBHCdlObxK7LRI5KwxKsEOLk-Ld-8QZo130_provenance.
- NP869741.RARrXXSyQevKDMBHCdlObxK7LRI5KwxKsEOLk-Ld-8QZo130_assertion SIO_000772 21289002 NP869741.RARrXXSyQevKDMBHCdlObxK7LRI5KwxKsEOLk-Ld-8QZo130_provenance.
- NP869741.RARrXXSyQevKDMBHCdlObxK7LRI5KwxKsEOLk-Ld-8QZo130_assertion wasDerivedFrom befree-2016 NP869741.RARrXXSyQevKDMBHCdlObxK7LRI5KwxKsEOLk-Ld-8QZo130_provenance.
- NP869741.RARrXXSyQevKDMBHCdlObxK7LRI5KwxKsEOLk-Ld-8QZo130_assertion wasGeneratedBy ECO_0000203 NP869741.RARrXXSyQevKDMBHCdlObxK7LRI5KwxKsEOLk-Ld-8QZo130_provenance.
- befree-2016 importedOn "2016-02-19" NP869741.RARrXXSyQevKDMBHCdlObxK7LRI5KwxKsEOLk-Ld-8QZo130_provenance.